For more information or confidential assistance
Call 800-306-3180

Xarelto MDL Bellwether Selection Underway

The process for determining which cases from the Xarelto multidistrict litigation in the Eastern District of Louisiana will be included in a bellwether discovery pool has been determined. U.S. District Judge Eldon Fallon issued a case management order on Nov. 20 outlining the selection criteria.... Read More

Four Plaintiffs File Joint Complaint in Xarelto MDL

Adding to the growing list of lawsuits in the Xarelto federal multidistrict litigation (MDL), a group of four plaintiffs have come together to file a joint complaint alleging that they each suffered serious harm after using Jannsen's anticoagulant drug. The highly detailed complaint outlines the... Read More

Xarelto Cases to be Selected for Bellwether Trials

Beginning shortly after its introduction in 2011, a number of plaintiffs have come forward alleging severe – and sometimes deadly – side effects with the anti-coagulant drug Xarelto. The drug, which was introduced to the market as a more convenient alternative to the traditional warfarin,... Read More

Evidence Shows that Xarelto is Passed From Mother to Fetus

woman holding pregnant belly
There is now documented evidence that Xarelto (rivaroxaban), the controversial anticoagulant used to reduce blood clots in patients with atrial fibrillation, transfers rapidly back and forth across the placenta between mother and fetus when ingested during pregnancy. A research team with The Motherisk Program at... Read More